Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Johnson & Johnson
Johnson & Johnson
Page 11 of 18
Health
J&J’s COVID vaccine could make its global debut as soon as next week
By
Contributing Writer
February 10, 2021
Health
The AstraZeneca COVID-19 vaccine (and possibly others) are ineffective against the South African variant
By
Staff Writer
February 8, 2021
Health
Johnson & Johnson’s lower-immunity single-dose COVID vaccine might be just what the doctor ordered
By
News Correspondent
February 1, 2021
Health
Why Europe’s summer COVID vaccination target could still be on track
By
Senior Editor
February 1, 2021
Magazine
The companies business leaders admire the most—and are watching closely
By
Matthew Heimer
and
Scott DeCarlo
February 1, 2021
Politics
Johnson & Johnson’s single-dose COVID-19 vaccine is 66% effective, lagging rivals
By
Tech Reporter
January 29, 2021
Newsletters
Stocks to watch under a Biden presidency
By
Staff Writer
January 26, 2021
Newsletters
Last week’s vaccine-led rally was one for the record books—but is all that good news already priced in?
By
Senior Editor
November 16, 2020
Health
The science behind the leading COVID vaccine candidates
By
Tech Reporter
November 4, 2020
Newsletters
Not even Big Tech can save investors from the latest markets plunge
By
Staff Writer
October 28, 2020
Newsletters
Here’s what could happen to your portfolio in the case of a ‘no deal’ on fiscal stimulus
By
Financial Writer
October 21, 2020
Health
As COVID-19 numbers boom and markets tank, Europe’s leaders urge vaccine coordination
By
Tech Reporter
October 15, 2020
Health
J&J CEO still optimistic COVID-19 vaccine could come as early as this year
By
Tech Reporter
October 14, 2020
Newsletters
Investors pull back on vaccine jitters and earnings woes
By
Senior Editor
October 14, 2020
Newsletters
Earnings season is here. Will companies deliver on the hype?
By
Digital Assets Editor
October 13, 2020
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Trading Desk
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Tech Reporter
Big Tech
Nvidia CEO says the company is in a no-win situation amid AI-bubble chatter, leaked meeting reveals
By
Research Team